Spero Therapeutics Inc (SPRO)
1.42
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
1.43
+0.01
(+0.70%)
After-Hours: 20:00
Spero Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.129M |
| June 30, 2022 | 50.00M |
| March 31, 2022 | -16.06M |
| December 31, 2021 | -23.28M |
| September 30, 2021 | 17.02M |
| June 30, 2021 | 10.92M |
| March 31, 2021 | 3.003M |
| December 31, 2020 | -39.74M |
| Date | Value |
|---|---|
| September 30, 2020 | 3.949M |
| June 30, 2020 | 18.48M |
| March 31, 2020 | 27.78M |
| December 31, 2019 | -4.099M |
| September 30, 2019 | -15.89M |
| June 30, 2019 | 24.84M |
| March 31, 2019 | 24.67M |
| December 31, 2018 | 7.287M |
| September 30, 2018 | -72.62M |
| June 30, 2018 | 5.00M |
| March 31, 2018 | -22.82M |
| December 31, 2017 | -0.027M |
| September 30, 2017 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-39.74M
Minimum
Dec 2020
50.00M
Maximum
Jun 2022
3.156M
Average
--
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics Inc | -1.808M |
| OptiNose Inc | -0.022M |
| scPharmaceuticals Inc | 29.32M |
| electroCore Inc | -- |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.938M |
| Free Cash Flow | -14.20M |
| Free Cash Flow Per Share (Quarterly) | 0.1109 |
| Free Cash Flow to Equity (Quarterly) | 5.938M |
| Free Cash Flow Yield | -18.79% |